Allan Jacobson, Ph.D. | University of Massachusetts Medical School
Allan Jacobson, Ph.D. is a co-founder of PTC and is the Gerald L. and Zelda S. Haidak Distinguished Professor of Cell Biology at the University of Massachusetts Medical School. He has served as a member of the PTC board of directors since the company's inception in 1998, previously served as Chairman of the board of directors from 1998 to 2004, and, since 2000, has served as Chairman of the scientific advisory board. In 1982, Dr. Jacobson co-founded Applied bioTechnology, Inc., a biotechnology company, and served as its chairman until its sale in 1991. From 1987 to 1990, Dr. Jacobson served as special limited partner at Euclid Partners, a venture capital firm. Dr. Jacobson has been the Chairman of the Department of Microbiology and Physiological Systems at the UMass Medical School since 1994, and in 2014, was awarded the Medical School’s Chancellor’s Medal for Distinguished Scholarship. Dr. Jacobson received a Ph.D. from Brandeis University in 1971, has authored over 100 publications in the field of post-transcriptional control processes, and is an elected member of the American Academy of Microbiology.
Eric N. Jacobsen, Ph.D. | Harvard University
Dr. Jacobsen is the Sheldon Emery Professor of Organic Chemistry at Harvard University. He is a consultant for Merck & Co., Inc. and Amgen, Inc. Dr. Jacobsen has received numerous awards for his endeavors, including the NSF Presidential Young Investigator Award (1990), the Packard Fellowship (1991), the Camille and Henry Dreyfus Teacher-Scholar Award (1992), the Alfred P. Sloan Foundation Fellowship (1992), the Cope Scholar Award (1993), the Fluka "Reagent of the Year" Prize (1994), the Thieme-IUPAC Prize in Synthetic Organic Chemistry (1996), the Baekeland Medal (1999), the ACS Award for Creativity in Synthetic Organic Chemistry (2001), election to the American Academy of Arts & Sciences (2004) , the ACS HC Brown Award for Creativity in Synthetic Methods (2008), election to the National Academy of Sciences (2008), the Chirality Medal (2012), and the ACS Arthur C. Cope Award (2016). Dr. Jacobsen received his Ph.D. in Organometallic Chemistry from the University of California, Berkeley.
Joseph (Jody) Puglisi, Ph.D | Stanford University
Dr. Puglisi is Professor in the Department of Structural Biology and Director of the Stanford Magnetic Resonance Laboratory (SMRL) at Stanford University School of Medicine. Dr. Puglisi is investigating the role of RNA in cellular processes and disease. His research addresses ribosome dynamics during translation, the molecular basis for antibiotic action against ribosomes, the mechanism of eukaryotic translation initiation and elongation, the structure and function of the hepatitis C virus internal ribosome entry site, and RNA-protein interactions in the human immunodeficiency virus. Dr. Puglisi obtained his Ph.D. in Biophysical Chemistry from the University of California, Berkeley and is a member of the National Academy of Sciences.
Robert Schneider, Ph.D. | NYU Clinical Translational Research Institute
Dr. Robert Schneider is the Albert Sabin Professor of Molecular Pathogenesis and Professor of Radiation Oncology at the NYU School of Medicine. In 2013 he became the inaugural Associate Dean for the Office of Therapeutics Alliances (OTA) at NYU Langone Medical Center, a virtual biotech drug discovery enterprise within the academic environment. Dr. Schneider is also an associate director for translational cancer research of the NYU Perlmutter Cancer Center, and co-leader of the breast cancer program. Dr. Schneider performs basic, translational and clinical research on the molecular basis of metastatic breast and ovarian cancers and the development of new therapeutics. His work also includes investigation of cancer stem cells and adult stem cells, and interconnections with the inflammatory response. He is the author of more than 150 peer-reviewed publications in oncology and inflammation. He has received a number of awards in recognition of his achievements, including the 2012 Susan E. Donelan Hope for the Future Award for breast cancer research, Dana Farber Cancer Institute; the 2011 Distinguished Alumnus Award & Commencement address, University of Delaware; and the 2010 Judah Folkman Memorial lecture, Chemotherapy Society. Dr. Schneider is a co-founding scientist of six biotechnology/small pharmaceutical companies. Dr. Schneider received his Ph.D. in biomedical sciences from the Mount Sinai School of Medicine and was a postdoctoral research fellow in the Department of Molecular Biology at Princeton University.
Marvin Wickens, Ph.D. | University of Wisconsin-Madison
Dr. Wickens is a Professor of Biochemistry at the University of Wisconsin-Madison. Dr Wickens is a former President of the RNA Society, the international association of RNA scientists, and recipient of their Lifetime Service Award. Dr Wickens has been elected to the American Academy of Arts and Sciences, in recognition of his numerous contributions to the understanding of the post-transcriptional control of gene expression. He has participated extensively in the peer review process at the National Institutes of Health (NIH), both as Chair of the NIH Molecular Biology Study Section (CDF-1) and as a member of the Advisory Board of the Center for Scientific Review, which oversees NIH's peer review process. He is an Associate Editor of the journals RNA, Molecular Biology of the Cell, PLoS Biology and EMBO Reports, and a recipient of Romnes and Mid-Career Development Awards from the University of Wisconsin, where he is the Max Perutz Professor of Molecular Biology. Dr. Wickens received his BS from UC Berkeley, his Ph.D. in Biological Sciences from Stanford University, and trained as a pos-doctoral fellow with Dr John Gurdon at the MRC Molecular Biology Lab in Cambridge, England.